Successful Salvage Therapy Including Tigecycline for Pediatric Mycobacterium abscessus Mastoiditis

Abstract

Get full access to this article

View all access options for this article.

References

Johansen

Herrmann

Kremer

Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol. 2020;18(7):392-407.

van Ingen

Boeree

van Soolingen

Mouton

JW.

Resistance mechanisms and drug susceptibility testing on nontuberculosis mycobacteria. Drug Resist Updat. 2012;15:149-161.

Lamb

Starke

JR.

Mycobacterium abscessus infection in children: a review of current literature. J Pediatric Infect Dis Soc. 2018;7:e131-e144.

van Ingen

Looijmans

Mirck

Dekhuijzen

Boeree

van Soolingen

. Otomastoiditis caused by Mycobacterium abscessus, the Netherlands. Emerg Infect Dis. 2010;16(1):166-168.

Sédillot-Daniel

Voizard

Vallières

Woods

Quintal

. Chronic suppurative otomastoiditis due to nontuberculous mycobacteria: a case series. Int J Pediatr Otorhinolaryngol. 2020;138:110375.

Yeh

C-F

T-Y

Wang

M-C

, et al. Emergence of refractory otomastoiditis due to nontuberculous mycobacteria: institutional experience and review of the literature. Clin Infect Dis. 2016;62:739-745.

Meir

Barkan

Alternative and experimental therapies of Mycobacterium abscessus infections. Internat J Mol Sci. 2020;21:6793.

Daley

Iaccarino

Lange

, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020;71:e1-36.

Wallace

Jr Dukart

Brown-Elliott

Griffith

Scerpella

Marshall

Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycob-acterium chelonae infections. J Antimicrob Chemother. 2014;69(7):1945-1953.

10.

van Wijk

Waterval

van Aerde

, et al. Successful systemic and topical treatment of Mycobacterium abscessus otomastoiditis. Antimicro Agents Chemother. 2020;64(1):e0120319.